Institut Claudius Regaud /ID# 225780

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Lung cancer

Running trials

• Active, not recruiting

  Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors

  NCT04721015· Phase 1· AbbVie· Source